Evaluation of the Brothers United Fatherhood Program
Public ClinicalTrials.gov record NCT03021226. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Impact Evaluation of the Brothers United Fatherhood Program, a Community-Based Responsible Fatherhood Initiative
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Brothers United Fatherhood Program (BUFP) will be conducting an evaluation that builds on literature and existing research from the healthy marriage/responsible fatherhood initiatives developed by ACF over the last 10 years, in particular the Supporting Healthy Marriage Program initiative that established a randomized clinical trial. The Brothers United Fatherhood Program will provide important data to expand the area of fatherhood development with the target population. This program is funded through an initiative of the Administration for Children and Families, Office of Family Assistance (OFA). The study is intended to measure if the identified interventions improve the well-being and relationship between targeted participants and their families. The study intends to focus on the following outcomes: * Demonstrate increased intake \& knowledge of systems that help fathers * Improvement in knowledge of employment \& learn new opportunities for economic mobility * Improvement communication \& empathy skills towards partner * Increase in understanding of healthy marriage \& its value to fathers * Demonstrate an understanding of financial planning * Demonstrate improved conflict resolution, behavior patterns, including those leading to domestic violence * Increase in reports of improved adult \& child relationships * Demonstrate an increase job readiness skills such as employment preparedness \& career direction
Study identification
- NCT ID
- NCT03021226
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 319 participants
Conditions and interventions
Conditions
Interventions
- Fatherhood Development Behavioral
- Relationship Enhancement Behavioral
- Financial Literacy Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 20 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016
- Primary completion
- Apr 26, 2020
- Completion
- Apr 26, 2020
- Last update posted
- Apr 27, 2020
2016 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pathway, Inc. | Toledo | Ohio | 43604 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03021226, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2020 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03021226 live on ClinicalTrials.gov.